EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A CDCA2–MYC positive feedback loop controls cancer cells survival

Konstantinos Stamatiou iD, Lorena Ligammari, Malki Bothota, Antonia Tsavou, Ezgi Gokhan, Ylenia Cicirò, Mariano Zacarias, Laura Soucek, Arturo Sala iD, Paola Vagnarelli iD

Open Biology · 11.03.2026 · 16 (3)

DOI: 10.1098/rsob.250075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Biology, online erschienen am 11.03.2026. Verfasst von Konstantinos Stamatiou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brunel University of London , London, UK. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Cell Cycle Proteins, Nuclear Proteins, Neoplasms. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Breast Cancer Now, Little Princess Trust, Kidscan Children's Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular myelocytomatosis oncogene (MYC) transcription factors are encoded by a family of genes that include the prototype member MYC, MYCN and MYCL, and most human cancers display expression alterations of MYC genes. MYC is regulated at multiple levels, and its stability and activity are modulated by protein phosphorylation. Although there is a reasonable knowledge of the kinases required for MYC modifications, the counteracting phosphatases have been understudied. Here, we have investigated the role of the chromatin-associated protein phosphatase 1 (PP1) regulatory subunit CDCA2, also known as Repo-Man, in the regulation of MYC proteins in cancer cells. Using RNA interference and degron-mediated degradation of CDCA2, we have demonstrated that the PP1 subunit is required for cMYC and MYCN stabilization and viability of triple-negative breast cancer, neuroblastoma and colon cancer cells. Proximity ligation assays indicate that both cMYC and MYCN are in close proximity to CDCA2 in vivo. Furthermore, we have shown that CDC2A is a bona fide MYC target gene in cancer cells, revealing a reciprocal regulatory loop that could be exploited for therapeutic purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mycCell Cycle ProteinsNuclear ProteinsNeoplasmsHumansCell Line, TumorN-Myc Proto-Oncogene ProteinGene Expression Regulation, NeoplasticCell SurvivalRNA InterferenceFeedback, PhysiologicalCDC2 Protein KinaseDegronsCarrier Proteins

Stichwörter der Autor:innen

CDCA2MYCMYCNneuroblastomaprotein phosphatase 1

Substanzen

Proto-Oncogene Proteins c-mycN-Myc Proto-Oncogene ProteinCell Cycle ProteinsCDCA2 protein, humanMYCN protein, humanCDC2 Protein KinaseMYC protein, humanNuclear ProteinsCDK1 protein, humanCarrier Proteins

Autor:innen und Institutionen

  • Brunel University of London , London, UK.
  • Hospital University Vall d'Hebron Campus , Barcelona, Spain.
  • Institució Catalana de Recerca i Estudis Avançats , Barcelona, Spain.

ORCID-Profile: Konstantinos Stamatiou, Arturo Sala, Paola Vagnarelli

Förderung

  • Breast Cancer Now
  • Little Princess Trust
  • Kidscan Children's Cancer Research

Zitieren

APA

Stamatiou, K., Ligammari, L., Bothota, M., Tsavou, A., Gokhan, E., Cicirò, Y., Zacarias, M., Soucek, L., Sala, A., & Vagnarelli, P. (2026). A CDCA2–MYC positive feedback loop controls cancer cells survival. Open Biology, 16(3). https://doi.org/10.1098/rsob.250075

Vancouver

Stamatiou K, Ligammari L, Bothota M, Tsavou A, Gokhan E, Cicirò Y, et al. A CDCA2–MYC positive feedback loop controls cancer cells survival. Open Biology. 2026;16(3). doi:10.1098/rsob.250075

BibTeX
@article{Stamatiou2026,
  author = {Stamatiou, Konstantinos and Ligammari, Lorena and Bothota, Malki and Tsavou, Antonia and Gokhan, Ezgi and Cicirò, Ylenia and Zacarias, Mariano and Soucek, Laura and Sala, Arturo and Vagnarelli, Paola},
  title = {A CDCA2–MYC positive feedback loop controls cancer cells survival},
  journal = {Open Biology},
  year = {2026},
  volume = {16},
  number = {3},
  doi = {10.1098/rsob.250075}
}
Kostenlos starten →